The study seeks to explore the benefits of an experimental drug as a potential new treatment of obsessive-compulsive disorder (OCD). The experimental drug changes activity in brain areas believed to be involved in OCD.
This study will involve approximately 8-10 weeks of study participation, including eight weeks of investigational treatment.